Heinz-Josef Lenz, Hao Xie, Daniel H. Ahn, David L. Bajor, Adel Kardosh, Alisha Heather Bent, Alex Kane, Ramanand Arun Subramanian, Alex Dmitrienko, Roger Sidhu, Joel R. Hecht. "Onvansertib plus standard-of-care chemotherapy plus bevacizumab in first-line RAS-mutated metastatic colorectal cancer (mCRC): Interim results from the phase 2 randomized CRDF-004 trial.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.3510